There are 2789 resources available
756P - Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
Presenter: Jinho Heo
Session: ePoster Display
757P - Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
Presenter: Yoo-Na Kim
Session: ePoster Display
802P - A machine learning-based framework for efficacy and safety analysis of PD-1PD-L1 inhibitor application in gynaecological cancer on incomplete post-marketing surveillance dataset
Presenter: xiaomei Liu
Session: ePoster Display
803P - An histopathological algorithm to help the search for POLE mutated endometrial cancers
Presenter: Leslie Tessier
Session: ePoster Display
759P - Adding dosing of plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy may provide clinical benefits to patients with platinum-resistant ovarian cancer
Presenter: Sergey Polyakov
Session: ePoster Display
760P - Straightforward molecular tests for predicting response and non-response to platinum-based neoadjuvant therapy in high-grade serous ovarian cancer patients
Presenter: Evgeny Imyanitov
Session: ePoster Display
806P - Genomic alteration characteristics and potential drug targets of uterine sarcoma
Presenter: Fengxia Xue
Session: ePoster Display
762P - Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes
Presenter: Camilla Sköld
Session: ePoster Display
808P - Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study
Presenter: Shin Nishio
Session: ePoster Display
809P - Comprehensive characterization of molecular features distinguishing uterine leiomyoma from leiomyosarcomas
Presenter: Xudong Liu
Session: ePoster Display